1. Home
  2. ELTX vs HIT Comparison

ELTX vs HIT Comparison

Compare ELTX & HIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$2.18

Market Cap

63.3M

Sector

Health Care

ML Signal

HOLD

Logo Health In Tech Inc.

HIT

Health In Tech Inc.

HOLD

Current Price

$0.94

Market Cap

74.1M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
HIT
Founded
2011
1964
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Insurers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
63.3M
74.1M
IPO Year
2014
2024

Fundamental Metrics

Financial Performance
Metric
ELTX
HIT
Price
$2.18
$0.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
2
Target Price
$18.00
$3.25
AVG Volume (30 Days)
266.2K
71.2K
Earning Date
05-12-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
39.29
100.00
EPS
N/A
N/A
Revenue
$2,301,000.00
$33,327,511.00
Revenue This Year
N/A
$41.00
Revenue Next Year
N/A
$69.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
70.99
52 Week Low
$2.34
$0.85
52 Week High
$16.00
$4.01

Technical Indicators

Market Signals
Indicator
ELTX
HIT
Relative Strength Index (RSI) 24.01 37.29
Support Level N/A $0.93
Resistance Level $3.32 $1.15
Average True Range (ATR) 0.13 0.05
MACD -0.03 -0.00
Stochastic Oscillator 1.09 9.44

Price Performance

Historical Comparison
ELTX
HIT

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

About HIT Health In Tech Inc.

Health In Tech Inc is an AI-enabled insurance technology platform company that offers a marketplace that improves processes in the healthcare industry through vertical integration, process simplification, and automation. By removing friction and complexities, it streamlines the underwriting, sales, and service process for insurance companies, licensed brokers, Managing General Underwriter (MGUs), and third-party administrators (TPAs). The company's platform serves as a marketplace for brokers, TPAs, MGUs and carriers with self-funded health insurance options for employers. The platform includes functions such as plan customization, stop-loss quoting, underwriting, claims administration, and reporting integration.

Share on Social Networks: